BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 20, 2002
View Archived Issues
Biomira, Merck KGaA Miss Early Theratope Endpoints
Setting the bar high usually brings about one of two results: an exalting triumph or falling flat. (BioWorld Today)
Read More
ISTA Secures $40M Financing As It Nears Vitrase NDA Filing
Read More
13 Is Lucky Number For Cohort In End-Stage Melanoma Treated With Counterintuitive Adoptive Transfer
Read More
Guilford Reports Positive Results From Follow-Up Of Gliadel Trial
Read More
Other News To Note
Read More
Endovasc Creates Subsidiaries For Two Late-Stage Products
Read More